Oncology Pharma Inc (ONPH)

[rrojarom]

So they convert debt at .0001 but issue to their directors/board at .01?
Whose ripping off who here?

On January 17, 2017, the Company issued 4,000,000 common restricted shares, at a cost of $0.0001 each, to reduce a note payable by $400.
On March 15, 2017 the Company issued 15,000,000 shares to each of 4 Directors at a cost of $0.01 per shares or a total cost of $600,000.
On June 22, 2017 the Company issued 10,000,000 common restricted shares at a cost of $0.0001 each, to reduce a note payable by $1,000.